Fund+, an investment firm focused on innovative European Life Sciences companies, announced that it has led the €38 million Series B financing in Indigo Diabetes. Indigo is developing a novel ‘invisible’ continuous glucose monitoring device for diabetics. Jan Van den Bossche, Partner at Fund+, will join the Board. Indigo has developed a small chip using…